Literature DB >> 24361022

Probiotics and liver disease.

Vishal Sharma1, Shashank Garg2, Sourabh Aggarwal3.   

Abstract

Intestinal microbiota play an important role in health and disease. The gut-liver axis provides for an interaction between bacterial components like lipopolysaccharide and hepatic receptors (Toll-like receptors). Dysbiosis and altered intestinal permeability may modulate this interaction and therefore result in hepatic disorders or worsening of hepatic disorders. Administration of health-promoting microbial strains may help ameliorate these harmful interactions and hepatic disorders. This review focuses on changes in gut microbiota in the context of liver disease and possible roles of probiotics, prebiotics, and synbiotics in liver disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24361022      PMCID: PMC3854811          DOI: 10.7812/TPP/12-144

Source DB:  PubMed          Journal:  Perm J        ISSN: 1552-5767


  56 in total

1.  Gut-liver axis: a new point of attack to treat chronic liver damage?

Authors:  Carmela Loguercio; Teresa De Simone; Alessandro Federico; Fulvia Terracciano; Concetta Tuccillo; Mauro Di Chicco; Maria Cartenì
Journal:  Am J Gastroenterol       Date:  2002-08       Impact factor: 10.864

2.  Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial.

Authors:  R Aller; D A De Luis; O Izaola; R Conde; M Gonzalez Sagrado; D Primo; B De La Fuente; J Gonzalez
Journal:  Eur Rev Med Pharmacol Sci       Date:  2011-09       Impact factor: 3.507

3.  Host-microbial interactions and regulation of intestinal epithelial barrier function: From physiology to pathology.

Authors:  Linda Chia-Hui Yu; Jin-Town Wang; Shu-Chen Wei; Yen-Hsuan Ni
Journal:  World J Gastrointest Pathophysiol       Date:  2012-02-15

4.  Characterization of fecal microbial communities in patients with liver cirrhosis.

Authors:  Yanfei Chen; Fengling Yang; Haifeng Lu; Baohong Wang; Yunbo Chen; Dajiang Lei; Yuezhu Wang; Baoli Zhu; Lanjuan Li
Journal:  Hepatology       Date:  2011-06-26       Impact factor: 17.425

5.  Role of gut microbiota in liver diseases.

Authors:  Yasuhiro Miyake; Kazuhide Yamamoto
Journal:  Hepatol Res       Date:  2012-09-13       Impact factor: 4.288

Review 6.  Lactulose: production, purification and potential applications.

Authors:  Parmjit S Panesar; Shweta Kumari
Journal:  Biotechnol Adv       Date:  2011-08-12       Impact factor: 14.227

7.  Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation--a randomized, double-blind trial.

Authors:  Nada Rayes; Daniel Seehofer; Tom Theruvath; Reinhold A Schiller; Jan M Langrehr; Sven Jonas; Stig Bengmark; Peter Neuhaus
Journal:  Am J Transplant       Date:  2005-01       Impact factor: 8.086

8.  Comparison of the gut microbe profiles and numbers between patients with liver cirrhosis and healthy individuals.

Authors:  Jianjun Liu; Dachang Wu; Ayaz Ahmed; Xinli Li; Yufang Ma; Li Tang; Dianjun Mo; Yue Ma; Yi Xin
Journal:  Curr Microbiol       Date:  2012-04-07       Impact factor: 2.188

9.  Intestinal dysbiosis: a possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats.

Authors:  Ece Mutlu; Ali Keshavarzian; Phillip Engen; Christopher B Forsyth; Masoumeh Sikaroodi; Patrick Gillevet
Journal:  Alcohol Clin Exp Res       Date:  2009-07-23       Impact factor: 3.455

10.  Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.

Authors:  Jorge Henao-Mejia; Eran Elinav; Chengcheng Jin; Liming Hao; Wajahat Z Mehal; Till Strowig; Christoph A Thaiss; Andrew L Kau; Stephanie C Eisenbarth; Michael J Jurczak; Joao-Paulo Camporez; Gerald I Shulman; Jeffrey I Gordon; Hal M Hoffman; Richard A Flavell
Journal:  Nature       Date:  2012-02-01       Impact factor: 49.962

View more
  9 in total

Review 1.  Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease.

Authors:  Giulia Paolella; Claudia Mandato; Luca Pierri; Marco Poeta; Martina Di Stasi; Pietro Vajro
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

2.  Effect of probiotics and synbiotics consumption on serum concentrations of liver function test enzymes: a systematic review and meta-analysis.

Authors:  Saman Khalesi; David Wayne Johnson; Katrin Campbell; Susan Williams; Andrew Fenning; Sonia Saluja; Christopher Irwin
Journal:  Eur J Nutr       Date:  2017-11-08       Impact factor: 5.614

Review 3.  Targeting gut microbiota in hepatocellular carcinoma: probiotics as a novel therapy.

Authors:  Murphy L Y Wan; Hani El-Nezami
Journal:  Hepatobiliary Surg Nutr       Date:  2018-02       Impact factor: 7.293

Review 4.  Gut Microbiota and Hepatocellular Carcinoma.

Authors:  Xueme Tao; Nin Wang; Wenxi Qin
Journal:  Gastrointest Tumors       Date:  2015-04-22

Review 5.  Role of bioactive fatty acids in nonalcoholic fatty liver disease.

Authors:  Eva Juárez-Hernández; Norberto C Chávez-Tapia; Misael Uribe; Varenka J Barbero-Becerra
Journal:  Nutr J       Date:  2016-08-02       Impact factor: 3.271

6.  Probiotic Survey in Cancer Patients Treated in the Outpatient Department in a Comprehensive Cancer Center.

Authors:  Sona Ciernikova; Michal Mego; Maria Semanova; Lenka Wachsmannova; Zuzana Adamcikova; Viola Stevurkova; Lubos Drgona; Vladimir Zajac
Journal:  Integr Cancer Ther       Date:  2016-05-05       Impact factor: 3.279

7.  Saccharomyces boulardii Administration Changes Gut Microbiota and Attenuates D-Galactosamine-Induced Liver Injury.

Authors:  Lei Yu; Xue-Ke Zhao; Ming-Liang Cheng; Guo-Zhen Yang; Bi Wang; Hua-Juan Liu; Ya-Xin Hu; Li-Li Zhu; Shuai Zhang; Zi-Wen Xiao; Yong-Mei Liu; Bao-Fang Zhang; Mao Mu
Journal:  Sci Rep       Date:  2017-05-02       Impact factor: 4.379

Review 8.  Probiotics in Medicine: A Long Debate.

Authors:  Elisavet Stavropoulou; Eugenia Bezirtzoglou
Journal:  Front Immunol       Date:  2020-09-25       Impact factor: 7.561

Review 9.  Probiotics: Evolving as a Potential Therapeutic Option against Acetaminophen-Induced Hepatotoxicity.

Authors:  Saikat Dewanjee; Tarun K Dua; Paramita Paul; Abhijit Dey; Jayalakshmi Vallamkondu; Sonalinandini Samanta; Ramesh Kandimalla; Vincenzo De Feo
Journal:  Biomedicines       Date:  2022-06-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.